From: Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes
Variable | Number of patients | Survival rate (%) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|
5-year | 10-year | P value | Relative risk (95% CI) | P value | ||
Age (years) | 0.123 | |||||
≤70 | 86 | 66 | 63 | |||
>70 | 49 | 52 | 49 | |||
Sex | 0.652 | |||||
Male | 41 | 66 | 61 | |||
Female | 94 | 59 | 57 | |||
Gallstone | 0.028 | 0.003 | ||||
Absent | 73 | 52 | 50 | 2.801 (1.435-5.470) | ||
Present | 62 | 72 | 68 | 1.000 | ||
Type of radical resection | <0.001 | |||||
Extended cholecystectomy | 93 | 77 | 76 | |||
Major hepatectomy | 19 | 9 | 9 | |||
Pancreaticoduodenectomy | 15 | 45 | 28 | |||
Major hepatectomy with pancreaticoduodenectomy | 8 | 25 | 25 | |||
Timing of radical resection | 0.007 | |||||
Initial radical resection | 111 | 56 | 52 | |||
Radical second resection | 24 | 86 | 86 | |||
Adjuvant chemotherapy | 0.093 | |||||
Absent | 85 | 57 | 52 | |||
Present | 50 | 68 | 68 | |||
Size of the primary tumor (mm) | 0.869 | |||||
≤60 | 68 | 61 | 59 | |||
>60 | 67 | 61 | 57 | |||
pT classification* | <0.001 | 0.005 | ||||
pT1 plus pT2 | 80 | 87 | 85 | 1.000 | ||
pT3 plus pT4 | 55 | 21 | 15 | 3.145 (1.412-6.948) | ||
Total lymph node count (TLNC) | 0.102 | |||||
≤16 | 76 | 66 | 66 | |||
>16 | 59 | 55 | 48 | |||
Location of positive lymph nodes* | <0.001 | |||||
pN0 | 76 | 80 | 80 | |||
pN1 | 24 | 57 | 46 | |||
pN2 | 35 | 23 | 20 | |||
Number of positive lymph nodes | <0.001 | 0.004 | ||||
0 | 76 | 80 | 80 | 1.000 | ||
1-3 | 39 | 51 | 41 | 1.640 (0.784-3.431) | ||
≥4 | 20 | 10 | 10 | 4.997 (1.905-13.003) | ||
Lymph node ratio (LNR; %) | <0.001 | |||||
0 | 76 | 80 | 80 | |||
0-10 | 22 | 60 | 49 | |||
>10 | 37 | 24 | 20 | |||
pM classification* | <0.001 | 0.014 | ||||
pM0 | 109 | 72 | 69 | 1.000 | ||
pM1 | 26† | 13 | 7 | 2.260 (1.178-4.337) | ||
Histological type* | <0.001 | |||||
Adenocarcinoma | 114 | 66 | 64 | |||
Others | 21 | 32 | 26 | |||
Histological grade* | 0.001 | <0.001 | ||||
G1 plus G2 | 96 | 68 | 67 | 1.000 | ||
G3 plus G4 | 39 | 42 | 34 | 3.472 (1.766-6.828) | ||
Lymphatic vessel invasion (L)* | <0.001 | |||||
L0 | 57 | 85 | 83 | |||
L1 | 78 | 44 | 41 | |||
Venous invasion (V)* | <0.001 | 0.007 | ||||
V0 | 74 | 78 | 76 | 1.000 | ||
V1 | 61 | 41 | 37 | 2.445 (1.279-4.673) | ||
Perineural invasion | <0.001 | |||||
Absent | 88 | 77 | 74 | |||
Present | 47 | 29 | 26 | |||
Residual tumor status* | <0.001 | 0.003 | ||||
R0 | 121 | 67 | 64 | 1.000 | ||
R1 plus R2 | 14 | 0 | 0 | 3.306 (1.519-7.195) |